CAR-T cell therapy: hidden heart risks?
NCT ID NCT06350994
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether CAR-T cell therapy, a new immunotherapy for blood cancers like leukemia and lymphoma, can cause early heart problems. Researchers will measure heart function with ultrasound before and a few days after treatment in 60 patients. The goal is to find out how often heart issues happen and what they look like, so doctors can better monitor and protect patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CAR-T cells
- What this could lead to
- If this trial succeeds, it could help doctors understand whether CAR-T cell therapy can cause early heart problems, leading to better monitoring and safer use of this treatment.
- What could go wrong
- This is a small, early observational study with only 60 participants, so results may not apply to all patients. It only looks at heart function a few days after treatment, not long-term effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Critical care medicine department
RECRUITINGParis, 75012, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can specially trained immune cells flush out hidden HIV?
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Frailty check may steer safer cancer care for seniors